Wild-type transthyretin cardiac amyloidosis: When is a rare disease no longer a rare disease?
J Nucl Cardiol
.
2021 Dec;28(6):2857-2859.
doi: 10.1007/s12350-020-02275-1.
Epub 2020 Jul 19.
Authors
Kshama Wechalekar
1
2
,
Ashutosh D Wechalekar
3
Affiliations
1
Department of Nuclear Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, UK. K.Wechalekar@rbht.nhs.uk.
2
Department of Nuclear Medicine, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK. K.Wechalekar@rbht.nhs.uk.
3
National Amyloidosis Centre, University College London, London, UK.
PMID:
32685989
DOI:
10.1007/s12350-020-02275-1
No abstract available
Publication types
Editorial
MeSH terms
Amyloid Neuropathies, Familial*
Humans
Prealbumin*
Rare Diseases
Substances
Prealbumin